EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 30-Oct-2026 04:16 ET (30-Oct-2026 08:16 GMT/UTC)

3-Jul-2026

Insilico Medicine shines at International Executive Summit, sharing the journey from tech innovation to clinical validation in AI drug discovery

July 7-10, 2026 | Geneva

Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.

July 8, 2026 | Beijing

Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the CITICS Global Consumer and Healthcare Forum 2026 in Beijing on July 8.

July 8-10, 2026 | Hong Kong

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the international science, technology, and information technology exhibition, LEAP EAST, held in Hong Kong from July 8 to 10.

3-Jul-2026

Hidden uncertainty: Human activity severs critical link between soil carbon and density in coastal zones

Chinese Society for Environmental Sciences
Peer-Reviewed Publication

Coastal wetlands are among the most powerful carbon sinks on the planet, but a new study reveals that the standard methods used to measure this stored carbon may be systematically underestimating uncertainty in coastal zones.

Journal: Environmental Science and Ecotechnology

3-Jul-2026

Aging-linked cells emerge as unexpected allies in tendon healing

Editorial Office of West China School of Stomatology, Sichuan University
Peer-Reviewed Publication

Chinese researchers led by Prof. Shen Liu from the Department of Orthopedics of the Shanghai Jiao Tong University School of Medicine have discovered that certain supporting cells expressing a protein marker called p16^INK4a, once associated with aging or stressed cells, were found to be key drivers of tendon healing. JMJD3, a molecular "switch," helped them turn on the repair genes. This pathway can be targeted to develop new treatment strategies for tendon injuries.

Journal: Bone Research

3-Jul-2026

Global heterogeneity and implementation gap in acute kidney injury prevention in ICUs: Results from the international AKI-PURIFY survey

Journal of Intensive Medicine
Peer-Reviewed Publication

The AKI-PURIFY survey provides a contemporary international overview of acute kidney injury (AKI) prevention and management practices in ICUs. Despite evidence supporting structured KDIGO-based preventive strategies, implementation remains inconsistent worldwide. Educational gaps, organizational barriers, and resource disparities significantly influence the adoption of evidence-based care. The survey highlights marked heterogeneity in diagnostic and renal replacement therapy practices, emphasizing the need for scalable training programs, audit systems, and context-sensitive implementation frameworks to improve AKI outcomes globally.

Journal: Journal of Intensive Medicine

3-Jul-2026

Diet changes could cut emissions without increasing food costs

University of Edinburgh
Peer-Reviewed Publication

Modest changes to meat and dairy consumption could help Scotland meet climate goals while improving health and nutrition, research shows.

Journal: Nature Food
Funder: Wellcome Trust, Food Standards Scotland

3-Jul-2026

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Harvard Medical School
Peer-Reviewed Publication

A new AI model called COMPASS uses tumor gene expression data to predict which patients will respond to cancer immunotherapy drugs called immune checkpoint inhibitors. Analyzing past data from 16 clinical cohorts, COMPASS predicted ICI response 8.5 percent more accurately than the best existing approach. If validated in clinical trials, the tool could lead to better precision medicine and cancer drug development.

Journal: Nature Medicine

3-Jul-2026

Radioligand therapy significantly prolongs progression-free survival in patients with the most common type of neuroendocrine tumors compared to standard of care

Vall d'Hebron Institute of Oncology
Peer-Reviewed Publication

Published in The Lancet, results of the phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [¹⁷⁷Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) when compared to targeted therapy with everolimus.

Journal: The Lancet

3-Jul-2026

Half of ICU survivors of bacterial meningitis still struggle 1 year later

Journal of Intensive Medicine
Peer-Reviewed Publication

In a post hoc analysis of 210 ICU-admitted patients from the French multicenter COMBAT cohort, nearly half of survivors of community-acquired bacterial meningitis still had unfavourable functional outcomes 1 year after intensive care. Hearing loss, depressive symptoms, and impaired physical quality of life were common, while fewer than half resumed work. The SOFA score on day 3 independently predicted 30-day mortality, highlighting the value of repeated organ function assessment.

Journal: Journal of Intensive Medicine
Funder: Assistance Publique - Hôpitaux de Paris, French Ministry of Health, Inserm, Société de Pathologie Infectieuse de Langue Française (SPILF), Pfizer, Société de Réanimation de Langue Française, Société Française d’Anesthésie-Réanimation.

3-Jul-2026

PFAS – an everlasting challenge

BfR Federal Institute for Risk Assessment
Reports and Proceedings

The term “forever chemicals” refers to per- and polyfluoroalkyl substances, or PFAS for short – a large group of industrial chemicals. These substances are resistant to high temperatures and aggressive chemicals, cannot be broken down in the environment, or only to a very limited extent, and are therefore extremely durable. “Due to their properties, PFAS are used in numerous industrial processes, technical applications and consumer products,” says BfR Vice-President Dr. Tewes Tralau. “However, due to their durability, they also accumulate in the environment, in plants and animals, and reach humans particularly via the food chain.” The extent to which certain PFAS can affect health is the focus of the new BfR2GO science magazine. The launch of the current issue also marks the launch of the BfR2GO website. Knowledge to take with you in the most literal sense!